LINC01432

Across TCGA pan-cancer cohorts, LINC01432 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC01432 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC01432 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01432 expression acts as an unfavorable survival marker, although some lineages such as ESCA and ACC show a favorable association.

KIRC, UCS, and KICH are the cancer types where LINC01432 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.410	0.645	<.001	114	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	108	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
THYM	DFS	Tertile	III,IV	0.174	0.813	<.001	87	view →
CESC	DFS	Tertile	III,IV	0.196	0.737	<.001	72	view →
LIHC	OS	Tertile	III,IV	0.162	0.645	<.001	60	view →
LUSC	DFS	Tertile	II,III,IV	0.079	0.750	<.001	51	view →
ESCA	OS	Tertile	III,IV	0.882	0.494	.013	36	view →
THCA	OS	Tertile	All	0.240	0.931	<.001	30	view →
PAAD	OS	Tertile	II,III,IV	0.211	0.561	<.001	18	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →
TGCT	DFS	Tertile	III,IV	0.017	0.923	.021	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LINC01432–KIRC (OS)

Open the KIRC breakdown →